Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis

Maria Pia Sormani, Robert Wolff*, Shona Lang, Steven Duffy, Robert Hyde, Elizabeth Kinter, Craig Wakeford, Gavin Giovannoni, Jos Kleijnen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)335-358
Number of pages24
JournalNeurology and Therapy
Volume9
Issue number2
Early online date25 Sep 2020
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Disease-modifying therapies
  • Healthcare decision-making
  • Mixed treatment comparison
  • Multiple sclerosis
  • Relapsing-remitting multiple sclerosis
  • DISEASE-MODIFYING THERAPIES
  • CARE DECISION-MAKING
  • ISPOR TASK-FORCE
  • NETWORK METAANALYSIS
  • DIAGNOSTIC-CRITERIA
  • GLATIRAMER ACETATE
  • DIMETHYL FUMARATE
  • INTERFERON-BETA
  • META-ANALYSIS
  • EFFICACY

Cite this